Ocrelizumab‐induced psoriasiform dermatitis: Case reports and review of the literature

Ocrelizumab‐induced psoriasiform dermatitis: Case reports and review of the literature

Abstract Ocrelizumab (OCR) is a humanized anti‐CD20 monoclonal antibody approved for treating multiple sclerosis. We present three patients who developed psoriasiform dermatitis (PsD) during OCR treatment and a review of the cases published to date. We hereby report the first exclusive fingernail in...

Full description

Saved in:
Bibliographic Details
Main Authors: Natalia Naranjo Guerrero (Author), Alicia González Quesada (Author), Angela García Minarro (Author), Elena Castro González (Author), Ana Begoña Paredes Pérez (Author), Gregorio Carretero Hernández (Author)
Format: Book
Published: Wiley, 2023-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items